|
Towards A Practical Alzheimer's Vaccine
(Monday September 19 2005)
 | Medical News Today reports on progress towards an Alzheimer's vaccine therapy in Austria: "The Vienna-based company Affiris is now reporting that it has succeeded in significantly reducing Alzheimer plaques by at least two-thirds in pre-clinical models by means of an innovative vaccine ... the Affiris approach not only avoids an autoimmune disease, but also offers the advantage of targeting simultaneously both the plaques and the soluble beta-amyloid fraction. Therefore, whether the soluble or plaque forms - or both - are responsible for causing the disease is not ultimately crucial for the vaccine's success." The company is aiming for human trials in 2006; the next few years should definitively show whether removing amyloid is a viable strategy for an Alzheimer's cure. |
|
